20/01/2021
Read full article here: https://www.biocentury.com/article/633601/rexgenero-rebrands-as-ikaxa-raises-40m-following-gene-therapy-deal
Read More
19/01/2021
Read full article here: https://endpts.com/a-cardiovascular-cell-therapy-player-grabs-54m-for-a-new-beginning-where-next-gen-car-t-approach-features-prominently/
Read More
18/01/2021
Read the full article https://www.biopharma-reporter.com/Article/2021/01/18/Rexgenero-has-been-renamed-Ixaka
Read More
26/10/2020
Read full article here: https://www.thepharmaletter.com/article/rexgenero-cleared-to-continue-phase-iii-trial-of-rex-001
Read More
02/07/2020
Read full article here: https://www.fiercebiotech.com/cro/british-cell-therapy-biotech-rexgenero-nabs-life-science-veteran-as-cmo
Read More
22/06/2020
Read full article here: https://www.thepharmaletter.com/article/rexgenero-buys-french-car-t-cell-specialist
Read More
22/06/2020
Read full article here: https://vascularnews.com/rexgenero-acquires-technology-programme-assets-aratinga/
Read More
02/01/2020
Read full article here: https://xconomy.com/national/2020/01/02/rexgenero-ceo-talks-importance-of-dialogue-in-cell-therapy-conversations/
Read More